These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 24404368)
1. Prevention of renal damage by treating hyperuricemia. Nickavar A Int J Prev Med; 2013 Nov; 4(11):1318-20. PubMed ID: 24404368 [TBL] [Abstract][Full Text] [Related]
2. Clinic-pathological characteristics of rare tubulointerstitial diseases. Shi K; Yuan S; Huang Y; Li Z; Wang C; Liu H; Sun L; Liu F; Zhu X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1365-1374. PubMed ID: 36411687 [TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia is an independent risk factor for renal pathological damage and poor prognosis in lupus nephritis patients. Xie T; Chen M; Tang X; Yin H; Wang X; Li G; Li J; Zuo X; Zhang W Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1052-1057. PubMed ID: 27807327 [TBL] [Abstract][Full Text] [Related]
4. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Kanbay M; Ozkara A; Selcoki Y; Isik B; Turgut F; Bavbek N; Uz E; Akcay A; Yigitoglu R; Covic A Int Urol Nephrol; 2007; 39(4):1227-33. PubMed ID: 17701281 [TBL] [Abstract][Full Text] [Related]
5. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Sánchez-Lozada LG; Tapia E; Santamaría J; Avila-Casado C; Soto V; Nepomuceno T; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J Kidney Int; 2005 Jan; 67(1):237-47. PubMed ID: 15610247 [TBL] [Abstract][Full Text] [Related]
6. Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Kosugi T; Nakayama T; Heinig M; Zhang L; Yuzawa Y; Sanchez-Lozada LG; Roncal C; Johnson RJ; Nakagawa T Am J Physiol Renal Physiol; 2009 Aug; 297(2):F481-8. PubMed ID: 19458127 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of acute and chronic hyperuricemia in kidney diseased patients. Bellinghieri G; Santoro D; Savica D Contrib Nephrol; 2005; 147():149-160. PubMed ID: 15604614 [TBL] [Abstract][Full Text] [Related]
8. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Sánchez-Lozada LG; Tapia E; Johnson RJ; Rodríguez-Iturbe B; Herrera-Acosta J Kidney Int Suppl; 2003 Oct; (86):S9-14. PubMed ID: 12969121 [TBL] [Abstract][Full Text] [Related]
9. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study. Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544 [TBL] [Abstract][Full Text] [Related]
10. Renal Effects of Hyperuricemia. Méndez Landa CE Contrib Nephrol; 2018; 192():8-16. PubMed ID: 29393089 [TBL] [Abstract][Full Text] [Related]
12. New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Filiopoulos V; Hadjiyannakos D; Vlassopoulos D Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409 [TBL] [Abstract][Full Text] [Related]
13. The Pathophysiology of Uric Acid on Renal Diseases. Sánchez-Lozada LG Contrib Nephrol; 2018; 192():17-24. PubMed ID: 29393088 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: Pathologic implications and putative pharmacologic targets. Balakumar P; Alqahtani A; Khan NA; Mahadevan N; Dhanaraj SA Pharmacol Res; 2020 Nov; 161():105209. PubMed ID: 32979505 [TBL] [Abstract][Full Text] [Related]
16. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]. Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518 [TBL] [Abstract][Full Text] [Related]
17. The assessment of renal function in patients with newly diagnosed hypertension - the role of hyperuricemia as a risk factor for chronic kidney disease - preliminary study. Komendarek-Kowalska M Pol Merkur Lekarski; 2017 May; 42(251):193-196. PubMed ID: 28557965 [TBL] [Abstract][Full Text] [Related]
18. Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy. Zhou J; Chen Y; Liu Y; Shi S; Li X; Wang S; Zhang H BMC Nephrol; 2014 Jan; 15():11. PubMed ID: 24423013 [TBL] [Abstract][Full Text] [Related]
19. Underexcretory-type hyperuricemia, disproportionate to the reduced glomerular filtration rate, in two boys with mild proteinuria. Murakami T; Kawakami H; Nakatsuka K; Jojima K; Nohno H; Matsuzaki H Nephron; 1990; 56(4):439-42. PubMed ID: 2080006 [TBL] [Abstract][Full Text] [Related]
20. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Johnson RJ; Kivlighn SD; Kim YG; Suga S; Fogo AB Am J Kidney Dis; 1999 Feb; 33(2):225-34. PubMed ID: 10023633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]